Showing 1 - 16 results of 16 for search 'Vicente Navarro-López', query time: 0.05s
Refine Results
-
1
A Resistome Roadmap: From the Human Body to Pristine Environments by Lucia Maestre-Carballa, Vicente Navarro-López, Manuel Martinez-Garcia
Published 2022-05-01
Article -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Selection of Probiotics in the Prevention of Respiratory Tract Infections and Their Impact on Occupational Health: Scoping Review by José Antonio Picó-Monllor, Beatriz Ruzafa-Costas, Eva Núñez-Delegido, Pedro Sánchez-Pellicer, Javier Peris-Berraco, Vicente Navarro-Lopez
Published 2021-12-01
Article -
12
Descriptive Study of Gut Microbiota in Infected and Colonized Subjects by <i>Clostridiodes difficile</i> by Pedro Sánchez-Pellicer, Vicente Navarro-López, Ruth González-Tamayo, Coral Llopis-Ruiz, Eva Núñez-Delegido, Beatriz Ruzafa-Costas, Laura Navarro-Moratalla, Juan Agüera-Santos
Published 2021-08-01
Article -
13
Bladder Cancer and Probiotics: What Do We Know So Far? by Pedro Sánchez-Pellicer, Claudia Boix-Rodríguez, Adriana Hernández-Belmonte, Cristina de la Encarnación-Castellano, Alberto Mendiola-López, Eva Núñez-Delegido, Laura Navarro-Moratalla, Juan Agüera-Santos, Vicente Navarro-López, Juan Antonio Galán-Llopis
Published 2023-11-01
Article -
14
Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial by Eric Climent, Juan Francisco Martinez-Blanch, Laura Llobregat, Beatriz Ruzafa-Costas, Miguel Ángel Carrión-Gutiérrez, Ana Ramírez-Boscá, David Prieto-Merino, Salvador Genovés, Francisco M. Codoñer, Daniel Ramón, Empar Chenoll, Vicente Navarro-López
Published 2021-04-01
Article -
15
Gut Microbiota as a Potential Predictive Biomarker in Relapsing-Remitting Multiple Sclerosis by Vicente Navarro-López, María Ángeles Méndez-Miralles, Rosa Vela-Yebra, Ana Fríes-Ramos, Pedro Sánchez-Pellicer, Beatriz Ruzafa-Costas, Eva Núñez-Delegido, Humberto Gómez-Gómez, Sara Chumillas-Lidón, Jose A. Picó-Monllor, Laura Navarro-Moratalla
Published 2022-05-01
Article -
16
Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial by Vicente Navarro-López, Adriana Hernández-Belmonte, Maria Isabel Pérez Soto, Maikel Ayo-González, Guillermo Losa-Rodríguez, Esther Ros-Sánchez, Maravillas Martínez-Gabarrón, Pedro Sánchez-Pellicer, Juan Aguera-Santos, Eva Núñez-Delegido, Beatriz Ruzafa-Costas, José Antonio Picó-Monllor, Laura Navarro-Moratalla
Published 2022-12-01
Article